News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Personalized Medicine Coalition Announces Two New Board Members



7/23/2008 9:22:02 AM

WASHINGTON--(BUSINESS WIRE)--The Personalized Medicine Coalition (PMC) today announced the appointment of Pierre G. Cassigneul, president and chief executive officer of XDx, Inc., and David P. King, chief executive officer, president and director of Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), to its Board of Directors. The PMC, an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine, was launched in 2004 by more than 15 leading pharmaceutical, biotechnology, diagnostics, and information technology companies, as well as major academic centers and governmental agencies, and now includes over 140 members representing all the stakeholders with an interest in personalized medicine.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES